EU puts drug compounds on pollutant list; Azaya forms CDMO; Mylan warned about unregistered Indian plant;

> The FDA has issued a Form 483 to Medi-Fare Drug and Home Health Center, a compounding pharmacy in Blacksburg, SC. Form (PDF)

> The European Union is adding three pharmaceutical compounds to its watch list for water pollutants. Story

> Private equity investor The Carlyle Group is buying the U.K.-based Chesapeake, which makes packaging for the pharmaceutical and other industries. Story

> New legislation in the U.S. will provide tax cuts and production credits to manufacturers of renewable chemicals. Story

> Azaya Therapeutics, which is developing oncology drugs using a nanotechnology platform, has formed Parexo Labs as a contract development and manufacturing organization (CDMO). Item

> The U.K.'s Aesica has hired Bashir Hansraj as Global Technical Director, who will implement the company's plan to create technical centers across the company's API and drug manufacturing and packaging network. Release

And Finally... Mylan Pharmaceuticals ($MYL) has been warned by the FDA that its plant in Hyderabad, Andhra Pradesh, India, needs to be registered. Letter